| Quarterly Financials | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 1,566 | 1,576 | 1,918 | 1,839 | 1,797 | 1,853 | 2,156 | 2,209 | 2,032 | 2,091 | 2,326 | 2,307 | 1,768 | 2,252 | 2,234 | 2,421 | 2,381 | 2,515 | 2,662 | 2,750 | 2,699 | 2,835 | 3,202 | 956 | 849 | 933 | 1,108 | 978 | 6,122 | 1,122 | 1,083 | 1,032 |
| Expenses | 1,517 | 1,428 | 1,643 | 1,521 | 1,651 | 1,714 | 1,891 | 1,851 | 1,806 | 1,842 | 1,955 | 1,878 | 1,618 | 1,972 | 1,900 | 2,070 | 2,091 | 2,162 | 2,253 | 2,267 | 2,370 | 2,498 | 2,744 | 687 | 747 | 856 | 806 | 861 | 841 | 869 | 888 | 845 |
| EBITDA | 49 | 148 | 276 | 318 | 146 | 139 | 265 | 358 | 226 | 249 | 371 | 429 | 150 | 280 | 335 | 351 | 290 | 353 | 409 | 482 | 329 | 337 | 458 | 269 | 102 | 78 | 302 | 117 | 5,281 | 252 | 195 | 187 |
| Operating Profit % | 3 % | 9 % | 9 % | 15 % | 7 % | 7 % | 12 % | 16 % | 11 % | 12 % | 16 % | 18 % | 8 % | 12 % | 15 % | 13 % | 12 % | 14 % | 15 % | 17 % | 11 % | 11 % | 14 % | 15 % | 11 % | 8 % | 16 % | 12 % | 16 % | 20 % | 15 % | 16 % |
| Depreciation | 79 | 95 | 68 | 56 | 74 | 76 | 79 | 78 | 126 | 149 | 140 | 171 | 155 | 153 | 157 | 153 | 153 | 156 | 161 | 170 | 175 | 189 | 198 | 54 | 51 | 54 | 57 | 58 | 60 | 62 | 62 | 64 |
| Interest | 43 | 46 | 49 | 47 | 40 | 40 | 56 | 55 | 88 | 88 | 72 | 112 | 80 | 75 | 62 | 77 | 67 | 61 | 67 | 62 | 69 | 77 | 87 | 25 | 25 | 30 | 25 | 30 | 29 | 32 | 31 | 32 |
| Profit Before Tax | -73 | 7 | 158 | 216 | 32 | 24 | 130 | 224 | 12 | 12 | 160 | 146 | -85 | 53 | 115 | 122 | 71 | 135 | 181 | 250 | 85 | 71 | 173 | 190 | 26 | -7 | 221 | 28 | 5,191 | 159 | 102 | 91 |
| Tax | 7 | 9 | -1 | 10 | 12 | 10 | 17 | 4 | 2 | 5 | 8 | -0 | 4 | 10 | 8 | 5 | 11 | 8 | 13 | 4 | 6 | 17 | 14 | 7 | 6 | 8 | 11 | 31 | 39 | 53 | 38 | 5 |
| Net Profit | -80 | -3 | 159 | 205 | 20 | 14 | 113 | 220 | 10 | 7 | 151 | 146 | -89 | 42 | 107 | 117 | 60 | 128 | 168 | 246 | 80 | 54 | 159 | 183 | 20 | -15 | 209 | -2 | 5,152 | 106 | 64 | 86 |
| EPS in ₹ | -1.66 | 0.01 | 3.33 | 4.07 | 0.25 | 0.22 | 2.00 | 4.10 | 0.06 | 0.06 | 2.78 | 2.61 | -1.67 | 0.66 | 1.86 | 2.12 | 0.89 | 2.15 | 2.98 | 4.55 | 1.38 | 0.93 | 2.80 | 3.43 | 0.10 | -0.62 | 3.60 | -0.48 | 103.34 | 1.94 | 1.14 | 1.59 |
Aster DM Healthcare
553.80
-16.00
(-2.81%)
Market Cap
27,663.00 Cr
EPS
2.60
PE Ratio
74.55
Dividend Yield
22.21 %
Industry
Healthcare Services52 Week High
609.50
52 Week Low
311.10
PB Ratio
9.19
Debt to Equity
0.87
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from7 analysts
Company News
View All News
Aster DM Healthcare: Q4 Profit Surge and GCC Business Separation4 days ago
Aster DM Healthcare reported a Q4 FY25 net profit of Rs 85.54 crore, compared to a loss in the previous year. FY25 consolidated revenue reached Rs 4,138.46 crore, showing 12% YoY growth. The company completed the separation of its GCC business, recording a gain of Rs 5,148.09 crore.
Aster DM Healthcare Reports Q4 Profit and Announces Dividend5 days ago
Aster DM Healthcare reported a consolidated net profit of 790.2 million rupees in Q4, compared to a loss of 240.3 million rupees in the same quarter last year. Revenue increased to 10 billion rupees from 9.74 billion rupees year-over-year. The company had an exceptional item loss of 264.2 million rupees. Profit before tax rose to 905.4 million rupees from 723.2 million rupees in the previous year. The company recommended a final dividend of 1 rupee per equity share.
Aster DM Healthcare: Q4 Profit Turnaround with 20% EBITDA Growth5 days ago
Aster DM Healthcare reported a Q4 net profit of ₹79 crore, reversing last year's loss. Revenue increased 2.7% to ₹1,000 crore. EBITDA rose 20.3% to ₹191.7 crore with margin expansion to 19.2%.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,177.10 | #1 1,14,430.80 | 101.05 | 5,584.10 | 18.77 | #1 1,058 | 26.84 | 57.57 | |
7,064.50 | 1,01,576.70 | 77.51 | #1 19,165.50 | 14.74 | 917 | 49.14 | 57.82 | |
719.05 | 54,285.30 | 64.11 | 6,931.20 | 8.99 | 645 | -7.43 | 61.88 | |
1,724.40 | 35,240.00 | #1 44.96 | 5,093.40 | 10.96 | 790 | 3.41 | 44.82 | |
1,219.90 | 32,765.00 | 63.13 | 2,759.20 | #1 25.09 | 326 | -20.35 | 51.90 | |
553.80 | #6 27,663.00 | #7 74.55 | #5 3,723.70 | #2 22.85 | #8 205 | #1 3,986.36 | 56.75 | |
672.90 | 26,925.30 | 71.59 | 2,511.20 | 12.94 | 336 | 48.39 | 60.33 | |
1,352.30 | 13,732.80 | 57.70 | 1,334.00 | 10.76 | 218 | 10.57 | 45.37 | |
1,459.30 | 9,568.00 | 49.50 | 1,095.50 | 21.32 | 177 | -0.88 | 52.00 | |
594.65 | 8,290.30 | 148.78 | 1,929.10 | 12.97 | 41 | -71.06 | 55.43 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
22.85 %
Net Income Growth
28.26 %
Cash Flow Change
-91.40 %
ROE
24.09 %
ROCE
100.72 %
EBITDA Margin (Avg.)
1.00 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 6,807 | 7,484 | 8,936 | 12,438 | 11,644 | 12,546 | 14,881 | 17,991 |
| Fixed Assets | 3,520 | 3,738 | 4,289 | 7,124 | 6,749 | 7,009 | 9,052 | 3,175 |
| Current Assets | 2,473 | 2,869 | 3,617 | 4,096 | 3,629 | 4,097 | 4,922 | 14,165 |
| Capital Work in Progress | 290 | 402 | 550 | 736 | 934 | 998 | 279 | 170 |
| Investments | 32 | 38 | 22 | 34 | 63 | 45 | 80 | 17 |
| Other Assets | 2,966 | 3,307 | 4,076 | 4,544 | 3,898 | 4,495 | 5,470 | 14,629 |
| Total Liabilities | 6,807 | 7,484 | 8,936 | 12,438 | 11,644 | 12,546 | 14,881 | 17,991 |
| Current Liabilities | 2,201 | 2,224 | 2,668 | 3,722 | 3,196 | 3,559 | 4,655 | 11,288 |
| Non Current Liabilities | 2,355 | 2,071 | 2,589 | 4,997 | 4,614 | 4,505 | 5,366 | 1,673 |
| Total Equity | 2,251 | 3,190 | 3,680 | 3,719 | 3,834 | 4,483 | 4,861 | 5,030 |
| Reserve & Surplus | 1,034 | 1,953 | 2,334 | 2,401 | 2,501 | 3,080 | 3,574 | 3,686 |
| Share Capital | 403 | 505 | 505 | 497 | 497 | 500 | 500 | 500 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -1 | 5 | -122 | 61 | 33 | -110 | 120 | 65 | 66 | 332 |
| Investing Activities | -439 | -775 | -1,136 | -522 | -702 | -658 | -333 | -563 | -951 | -878 |
| Operating Activities | 236 | 203 | 361 | 537 | 601 | 1,223 | 1,569 | 1,314 | 1,834 | 158 |
| Financing Activities | 203 | 578 | 654 | 46 | 134 | -675 | -1,116 | -686 | -817 | 1,053 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Apr 2025 |
| Promoter | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.89 % | 40.38 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 33.09 % | 29.09 % | 29.09 % | 40.21 % | 29.09 % | 33.48 % | 27.08 % | 23.85 % | 22.62 % | 21.66 % | 11.86 % |
| DIIs | 7.81 % | 8.73 % | 7.78 % | 7.87 % | 8.12 % | 9.62 % | 8.94 % | 8.93 % | 8.94 % | 8.56 % | 7.64 % | 7.15 % | 13.70 % | 16.35 % | 20.91 % | 22.91 % | 24.59 % | 24.09 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 3.70 % | 4.44 % | 4.21 % | 4.33 % | 3.92 % | 3.70 % | 3.43 % | 3.34 % | 3.18 % | 3.39 % | 3.15 % | 2.96 % | 3.09 % | 6.98 % | 5.94 % | 5.04 % | 4.38 % | 4.12 % |
| Others | 50.61 % | 48.94 % | 50.12 % | 49.92 % | 50.08 % | 48.80 % | 49.75 % | 16.76 % | 16.92 % | 17.08 % | 7.11 % | 18.93 % | 7.85 % | 7.72 % | 7.42 % | 7.55 % | 7.49 % | 19.56 % |
| No of Share Holders | 0 | 78,719 | 93,506 | 87,804 | 80,746 | 80,427 | 78,374 | 80,913 | 82,129 | 71,379 | 67,673 | 67,331 | 80,931 | 2,06,660 | 1,74,171 | 1,59,038 | 1,54,014 | 1,51,664 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.41 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 May 2025 |  Quarterly Result Announcement | NA | 20 May 2025 | 550.10 | 584.15 |
| 10 Feb 2025 |  Dividend | ₹ 4.00 /share | 10 Feb 2025 | 485.30 | 473.20 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 494.65 | 485.30 |
| 23 Oct 2024 | Quarterly Result Announcement | NA | 23 Oct 2024 | 427.95 | 405.20 |
| 29 Aug 2024 |  Annual General Meeting | NA | 29 Aug 2024 | 379.30 | 409.90 |
| 22 Aug 2024 | Dividend | ₹ 2.00 /share | 22 Aug 2024 | 375.20 | 401.15 |
| 23 Apr 2024 | Dividend | ₹ 118.00 /share | 23 Apr 2024 | 475.25 | 513.35 |
| 31 Aug 2023 | Annual General Meeting | NA | 31 Aug 2023 | 312.45 | 331.20 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome4 days ago
4 days agoAnnouncement Under Regulation 30 Of SEBI (LODR) 20154 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation5 days ago
5 days agoCautionary Letter/Email5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Change in Management5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Dividend Updates5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
5 days agoIntegrated Filing (Financial)5 days ago
5 days agoBoard Meeting Outcome for The Meeting Held On May 20 20255 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
10 days agoBoard Meeting Intimation for The Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2025May 14, 2025
May 14, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 07, 2025
May 07, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.May 07, 2025
May 07, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.May 07, 2025
May 07, 2025Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsMay 06, 2025
May 06, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 30, 2025
Apr 30, 2025Announcement under Regulation 30 (LODR)-AllotmentApr 29, 2025
Apr 29, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 18, 2025
Apr 18, 2025Intimation Of Competition Commission Of India (CCI) ApprovalApr 16, 2025
Apr 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2025
Apr 14, 2025Report On Violation Of Code Of Conduct Under SEBI (Prohibition Of Insider Trading) Regulations 2015Mar 31, 2025
Mar 31, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsMar 27, 2025
Mar 27, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Mar 25, 2025
Mar 25, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Mar 25, 2025
Mar 25, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 24, 2025
Mar 24, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Mar 24, 2025
Mar 24, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Mar 24, 2025
Mar 24, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 20, 2025
Mar 20, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 14, 2025
Mar 14, 2025Intimation Of In-Principle Approval Received For Issue And Allotment Of 18607969 (One Crore Eighty Six Lakhs Seven Thousand Nine Hundred And Sixty Nine) Equity Shares Of The Company On Preferential Basis For Consideration Other Than CashMar 13, 2025
Mar 13, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Mar 11, 2025
Mar 11, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Mar 11, 2025
Mar 11, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 10, 2025
Mar 10, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 07, 2025
Mar 07, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Mar 05, 2025
Mar 05, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Mar 05, 2025
Mar 05, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Mar 05, 2025
Mar 05, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Mar 05, 2025
Mar 05, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 05, 2025
Mar 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 04, 2025
Mar 04, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 03, 2025
Mar 03, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Mar 03, 2025
Mar 03, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Mar 03, 2025
Mar 03, 2025Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Feb 28, 2025
Feb 28, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Feb 28, 2025
Feb 28, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 27, 2025
Feb 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 14, 2025
Feb 14, 2025Technical Indicators
RSI(14)
Neutral 56.75
ATR(14)
Less Volatile 22.22
STOCH(9,6)
Neutral 52.31
STOCH RSI(14)
Oversold 7.82
MACD(12,26)
Bearish -1.47
ADX(14)
Strong Trend 33.07
UO(9)
Bearish 36.37
ROC(12)
Uptrend And Accelerating 3.51
WillR(14)
Neutral -55.15
About Aster DM Healthcare
Aster DM Healthcare is a healthcare service provider operating in the GCC and India. Founded in 1987 by Dr. Azad Moopen, the company offers a range of healthcare services through a network of hospitals, clinics, pharmacies, and labs. As of March 2023, Aster DM Healthcare operates 32 hospitals, 127 clinics, 521 pharmacies, and 205 labs and patient experience centers across multiple countries. The company provides primary, secondary, tertiary, and quaternary care, as well as healthcare retailing, diagnostic services, digital health, and medical education. In India, Aster DM Healthcare has 17 hospitals with 4,317 beds, and its operations span across several states including Kerala, Karnataka, Maharashtra, Andhra Pradesh, and Telangana. The company also has a significant presence in GCC countries, with hospitals and clinics in UAE, Oman, Qatar, Bahrain, and Kuwait.
Listing Date
26 Feb, 2018(7 Years,
0 days)
Chairperson NameMandayapurath Azad Moopen
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
